Understanding the Diagnosis: Biology and Confirmation

Ataxia-Telangiectasia (A-T) is a rare, complex genetic condition that affects multiple systems in the body, including the nervous system and the immune system ^[1][2]. Because it is so rare—estimated to occur in only 1 in every 40,000 to 100,000 live births—many local pediatricians may have never treated a case ^[2][3]. Understanding the biology behind the condition is the first step in navigating care.

The ATM Gene: The Cell’s Repair Manager

At its core, A-T is a DNA repair disorder ^[1]. Every day, the cells in our bodies experience minor damage to their DNA. The most serious type of damage is a double-strand break, where both “rails” of the DNA ladder are snapped ^[4].

In a healthy body, the ATM gene acts like a master manager or a “first responder” ^[5]. When a break is detected, the ATM protein is activated and immediately sends signals to the rest of the cell to ^[6][4]:

• Stop the cell cycle: It freezes the cell’s growth process so the damage isn’t copied into new cells.
• Organize the repair crew: It recruits other proteins to stitch the DNA back together ^[7].
• Trigger “self-destruct” (Apoptosis): If the damage is too severe to fix, ATM signals the cell to safely dismantle itself so it doesn’t become a threat (such as a cancer cell) ^[6].

In A-T, the ATM gene has pathogenic variants (mutations) on both copies (one inherited from each parent), a state known as biallelic ^[2][3]. Without a working “manager,” DNA breaks go unrepaired or are fixed incorrectly. This instability leads to the progressive loss of brain cells (neurodegeneration), a weakened immune system, and an increased risk of certain cancers ^[1][8].

Why A-T is Often Misdiagnosed

Diagnosis can be a long and frustrating journey. In the early years, A-T can initially resemble Cerebral Palsy (CP) ^[9]. This happens because both conditions can cause early balance issues, a waddling gait, or involuntary movements ^[9][10].

The key difference is that Cerebral Palsy arises from a nonprogressive brain injury, whereas A-T is a progressive condition ^[9]. Regression or new neurologic findings warrant specialist reassessment. As a child grows, the symptoms of A-T become more distinct, but this can take years. Some children are not correctly diagnosed until age 8 or even later ^[9][11].

Doctors must also rule out AOA2 (Ataxia with Oculomotor Apraxia Type 2). Both A-T and AOA2 cause balance issues and similar eye-movement changes, but they are caused by different genes ^[12][13]. AOA2 usually appears later in childhood and typically involves lower levels of certain blood markers than A-T ^[14].

Evaluating and Confirming the Diagnosis

A definitive diagnosis of A-T is established by identifying biallelic pathogenic ATM variants. However, doctors use several components in their evaluation:

1. Genetic Testing

The definitive confirmation relies on identifying pathogenic variants in the ATM gene ^[2].

• Variants must be present on both copies of the gene to establish A-T ^[3].
• Testing should include both “sequencing” (reading the DNA code) and “deletion/duplication analysis” (checking for large missing or extra chunks of DNA) ^[3][15].

If genetic tests are unclear, doctors can perform a functional assay ^[15]. This is a specialized lab test that looks directly at the ATM protein in the cells to see if it is present and if it can still “manage” DNA repair ^[2][16].

2. Serum AFP (Alpha-fetoprotein)

AFP is a supportive marker normally found at high levels in newborns, but it should drop significantly as a child grows. In most individuals with A-T, AFP levels are abnormally high ^[2].

• The Age Factor: AFP must be interpreted using the laboratory’s age-specific range. It is often normal or less informative in young children because the natural newborn levels haven’t finished dropping yet ^[17].
• The Rise: In most classic A-T cases, the elevation becomes clear after approximately age two ^[17]. A normal test at age 1 does not rule out A-T.

3. Immune System Panel

Because the ATM gene helps the immune system develop, patients often have specific deficiencies ^[18]. A supportive workup includes:

• Immunoglobulins: Checking levels of IgA, IgG, and IgM (the body’s primary germ-fighters) ^[19].
• T-cell counts: Patients with A-T often have low numbers of certain white blood cells ^[2][19]. Note that a normal immune panel does not exclude A-T.

The Importance of a Correct Diagnosis

Getting the right diagnosis is vital for safety. For example, individuals with A-T are highly sensitive to ionizing radiation (like X-rays and CT scans) ^[20][21]. Knowing the diagnosis allows the medical team to use safer imaging alternatives when appropriate and begin specific monitoring for lung health and other complications ^[8][18]. Genetic counseling is also strongly recommended to explain autosomal-recessive inheritance, carrier status, and testing of siblings.